Brief: Natera Provides Update on Patent Litigation with NeoGenomics
29/08/2025 13:19
Aug 29 (Reuters) - Natera Inc NTRA.O: NATERA PROVIDES UPDATE ON PATENT LITIGATION WITH NEOGENOMICS NATERA INC - EVALUATING OPTIONS INCLUDING APPEAL NATERA INC - COURT DECISION DOES NOT IMPACT U.S. PATENT NO. 11,519,035 Source text: ID:nBw559w9Ja Further company coverage: NTRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natera
See all newsBrief: FDA Grants Breakthrough Device Designation For Natera’S Multi-Cancer Early Detection Assay
Brief: Alliance Foundation Trials And Natera Announce Aft-70 Navigate A Global, Randomized, Phase Iii Trial Evaluating Genentech’S Oral Selective Estrogen Receptor Degrader With Signatera Mrd-Guided Cdk4/6 Inhibitor Therapy In Breast Cancer
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
Brief: Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027
Brief: Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers